PMDD in Perimenopause: Why It Often Gets Harder Before It Ends

For about ten days a month, you are not yourself.

Then your period arrives and it lifts, almost like a switch, and you spend the good weeks wondering whether you imagined how bad the bad ones were. Then it happens again.

PMDD in perimenopause is one of the most disorienting things the transition does, partly because the pattern that used to be predictable stops being predictable.

The women who raise this with us have almost always tracked it themselves first, on a phone calendar, because nobody believed the timing was that predictable.

What Is PMDD, and How Is It Different From PMS?

Almost everyone who menstruates notices something premenstrual. PMDD is a different order of thing.

The distinction that matters clinically is not how many symptoms you have. It is the timing and the impairment: symptoms that appear reliably in the luteal phase, are severe enough to damage relationships or work, and then clear once your period arrives.

How common it is depends entirely on how carefully it is diagnosed, and that turns out to be the most useful fact on this page.

A 2024 systematic review by Reilly and colleagues pooled 44 studies covering just over fifty thousand women. It found the rate to be about three in every hundred when the diagnosis was properly confirmed, and closer to eight in every hundred when it was based on recall.

Those two are pooled global figures with very wide margins. The same review reports a cleaner number: restricted to community samples with a confirmed diagnosis, the rate was about one and a half in every hundred women, and the studies agreed with each other far more closely.

The gap is the point either way. The apparent rate more than doubles when nobody checks properly, and the authors conclude that studies relying on recalled symptoms are likely to produce artificially high rates. That cuts both ways: over-diagnosis, and for women dismissed over many years, under-diagnosis.

Does PMDD Get Worse in Perimenopause?

This is the question that brings most women to this page, so it deserves a straight answer rather than a confident one.

Reviewing what is known about premenstrual mood symptoms in the perimenopause, Sander and Gordon describe two distinct vulnerabilities. In the early transition, when hormone levels swing upward rather than simply declining, a subset of women experience depressed mood in response to those elevations. Later, in the late transition and early postmenopause, a different subset becomes more sensitive to hormone withdrawal.

Either way the input has changed. A system that was already unusually reactive to hormone movement is now being given far more movement to react to.

Here is where we will not overstate it. That same review says plainly that more research is needed to clarify what happens to premenstrual dysphoria across the transition, and concludes only that providers should be alert to possible worsening. We looked for direct longitudinal evidence on PMDD specifically through perimenopause and did not find any worth citing to you. Vigilance is the supported claim. Certainty is not.

One practical consequence is real regardless. As cycles become irregular, the luteal phase stops arriving on schedule, so the symptom pattern that used to be predictable becomes hard to anticipate. Many women read that unpredictability as the condition getting worse, when part of it is the calendar coming apart. Our guide to what happens during perimenopause covers that cycle change in more detail.

Why Do Your Hormone Levels Come Back Normal?

If you have been told your labs look fine and left it there, this section is the one to read twice.

Schmidt and colleagues at the National Institute of Mental Health ran the experiment that settled this in 1998. They suppressed ovarian function with leuprolide, a drug that temporarily shuts the cycle down, and symptoms improved. Then, still on the suppressing drug, they added back estradiol for four weeks and progesterone for four weeks, blinded.

Symptoms returned significantly with either hormone in the women with premenstrual syndrome, and not at all in the women without it, even though both groups received identical hormones. The paper states outright that these women have no evidence of ovarian dysfunction.

Wei and colleagues repeated it with a substantially larger sample and published the expanded findings in 2025, comparing 34 women with PMDD against 76 without across the same suppression and add-back conditions. This is not a fragile old result.

So a normal hormone panel is not evidence against PMDD. It is what the research predicts you will find. That single reframe is the difference between a woman leaving an appointment believing nothing is wrong with her and leaving it with a plan.

How Is PMDD Actually Diagnosed?

This is the step that gets skipped, and skipping it is why so many women spend years being told different things by different clinicians.

The diagnostic standard is prospective daily rating. Eisenlohr-Moul and colleagues built and validated a scoring system for applying the formal criteria to two or more months of daily records, and it agreed with expert clinician diagnosis about ninety-eight times out of a hundred. Their work also confirms what the prevalence gap already implied: retrospective reports of premenstrual symptoms do not hold up.

In practice, that means logging a small set of symptoms each evening for two full cycles before anyone concludes anything:

• Mood, rated the same way each day rather than described in words
• Irritability and anger, which women under-report and partners often notice first
• Anxiety and a sense of being overwhelmed
• Physical symptoms such as breast tenderness, bloating and sleep changes
• Whether the day was affected at work or at home, which is what separates PMDD from ordinary premenstrual symptoms
• The first day of bleeding, which is the anchor the whole record depends on

Two things make this harder in perimenopause, and both are worth naming. Cycles get irregular, so the luteal phase is a moving target. And if you have skipped periods, there may not be two clean cycles to record. That is a reason to start tracking sooner rather than a reason to skip it.

The distinction the tracking is really for

Daily records do not only confirm PMDD. They separate it from the condition it is most often confused with.

Yonkers and Simoni group the premenstrual disorders to include premenstrual worsening of another condition, which is a different thing entirely: depression, anxiety or another disorder that is present all month and gets worse before your period, rather than a disorder that exists only in the luteal phase.

On a chart the two look nothing alike. In PMDD the symptoms return to baseline after bleeding starts. In premenstrual worsening they never reach baseline, they just get worse and then less bad. It is treated differently, and it is the reason a clinician wants the whole month recorded rather than only the bad week.

What Treatments Work for PMDD in Perimenopause?

The most useful thing to know is that the strongest evidence here is not hormonal, which surprises women who came looking for a hormone answer.

Serotonergic antidepressants, continuous or luteal only

These are first-line for PMDD, and they can be dosed in a way that has no equivalent in ordinary depression treatment: only during the second half of the cycle.

Three are approved in the US specifically for PMDD: fluoxetine, sertraline and controlled-release paroxetine.

Reilly and colleagues compared the two dosing approaches directly, pooling eight trials covering 460 participants. They found no statistically significant difference in response between luteal-only and continuous dosing.

That is not the same as proving them equivalent. The confidence interval was wide enough to allow a substantial advantage in either direction, every included trial carried a moderate or high risk of bias, and eight small trials is not much to go on.

What the authors do conclude is that because intermittent dosing avoids the withdrawal problem of stopping a continuously dosed antidepressant, it deserves to be considered more often than it is.

If irregular cycles have made the luteal phase hard to identify, continuous dosing becomes the more practical of the two. That is a scheduling problem, not a clinical downgrade.

Where hormonal treatment fits

There is one hormonal treatment with real evidence behind it, and it is not the one most women expect. Reviewing the field, Yonkers and Simoni identify the most effective options for PMDD as serotonin reuptake inhibitors and contraceptives with a shortened or absent hormone-free interval.

The formulation with the strongest trial evidence is a combined pill containing drospirenone taken on a 24-day active, 4-day inactive schedule. Yonkers and colleagues tested it against placebo in 450 women with PMDD across three treatment cycles, and symptom scores improved significantly more on the active pill, across mood, physical and behavioral symptoms.

We do not prescribe contraception at Tactus Health. That belongs with your gynecologist or primary care provider, and it is worth raising with them by name, because a great many women are never told this option exists for this diagnosis.

The picture is genuinely more complicated in perimenopause than outside it, because two different problems can be present at once: a cyclical mood disorder, and the mood effects of the transition itself.

A US expert panel convened to write guidelines for evaluating and treating perimenopausal depression, led by Maki and colleagues, set out how these should be assessed rather than assumed. We cover the hormonal side of midlife mood separately in our guide to hormone therapy, mood and depression, and the general pattern of transition mood changes on our mood swings page.

We diagnose and treat PMDD at Tactus Health, including prescribing and monitoring the serotonergic antidepressants above. What we do not prescribe is contraception, so if the drospirenone option is the right one for you, that belongs with your gynecologist or primary care provider.

The evaluation comes first either way: establishing whether the pattern is genuinely cyclical, checking the things that mimic it, and reviewing the hormonal picture. Dr. Ashar sets the protocols our medical team follows.

What we are not going to tell you

That progesterone fixes this. It is a common claim, and the add-back research above is exactly why we are careful with it: in women who had the condition, adding progesterone brought the symptoms back.

Low progesterone is a real and separate issue with its own evaluation and treatment, and sleep deserves addressing on its own terms too, which we cover in our guide to sleep in perimenopause. Neither one is a PMDD treatment.

Women with PMDD also frequently describe worsening attention and focus in the luteal phase. That overlap is real and it deserves its own page rather than a paragraph here. Broughton and colleagues put numbers on it: provisional PMDD was about three times as common in women with a clinical ADHD diagnosis as in those without. Those women were aged eighteen to thirty-four and the screening tool identifies provisional rather than confirmed PMDD, so it establishes the link rather than giving a rate for midlife. Our guide to ADHD and menopause covers what that means at this stage of life.

When Should You Contact a Provider?

Reviewing the published research on this specifically, Osborn and colleagues examined suicidality in women with PMDD and set out why it warrants direct attention rather than reassurance that it lifts with the period.

Questions Patients Ask Us About PMDD in Perimenopause

Can PMDD start in perimenopause if I never had it before?

New severe cyclical mood symptoms in midlife are more often the mood effects of the transition itself than newly arrived PMDD, and the two are treated differently. The way to tell them apart is the timing: PMDD symptoms clear once bleeding starts, while transition-related mood changes do not track the cycle that cleanly. That is what daily tracking is for.

Will HRT fix PMDD?

It is not a PMDD treatment, and the research is a reason for genuine caution. In the ovarian suppression studies, adding back either estradiol or progesterone brought symptoms back in women with the condition. Hormone therapy may still be appropriate for transition symptoms happening alongside it, which is a separate assessment rather than the same one.

Why did my doctor say my hormones are normal?

Because they almost certainly are. Women with PMDD have normal ovarian function, and the difference lies in how sensitively the brain responds to ordinary hormone change. No blood test diagnoses PMDD, so a normal panel is the expected result rather than evidence against you.

Does PMDD go away after menopause?

The symptoms of PMDD are tied to the luteal phase, so once ovulation stops the cyclical pattern has nothing to run on. What is less predictable is the road there, since some women become more sensitive to hormone withdrawal during the late transition. Symptoms ending is not the same as the transition being easy.

How do I get diagnosed with PMDD?

By rating symptoms daily across at least two cycles before any conclusion is drawn. A validated scoring system applied to two or more months of daily records agreed with expert clinicians about ninety-eight times out of a hundred, while recalled symptoms proved unreliable. Start the record before the appointment, since it is the part that takes the longest.

Is PMDD just severe PMS?

No. It is a distinct diagnosis, defined by the severity of the mood symptoms and by how tightly they lock to the luteal phase and lift once the period starts. The practical difference is impairment: PMDD damages work and relationships in a way ordinary premenstrual symptoms do not.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Co-Founder & Medical Director at Tactus Health, and board certified in psychiatric mental health as well as family practice. Clinical focus on hormone therapy, medical weight loss, and aesthetics. Sugar Hill, GA and telehealth for Georgia patients.